| Schedule of Basic and Diluted Net Loss per Share Attributable to Ordinary Shareholders |
The computation of basic and diluted net loss per share is as follows (in thousands, except per share data): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three months ended June 30, | | Six months ended June 30, | | | 2026 | | 2025 | | 2026 | | 2025 | | Numerator: | | | | | | | | | | Net loss from continuing operations | | $ | (36,927) | | | $ | (31,184) | | | $ | (33,025) | | | $ | (37,445) | | | Net loss from discontinued operations, net of tax | | (6,609) | | | (725) | | | (30,930) | | | (10,703) | | | Net loss | | $ | (43,536) | | | $ | (31,909) | | | $ | (63,955) | | | $ | (48,148) | | | | | | | | | | | | Preferred stock dividends and accretion | | (990) | | | (891) | | | (1,980) | | | (1,782) | | | | | | | | | | | | | | | | | | | | | Net loss attributable to common stockholders | | $ | (44,526) | | | $ | (32,800) | | | $ | (65,935) | | | $ | (49,930) | | | Denominator: | | | | | | | | | | Weighted average shares of common stock outstanding - basic | | 280,129 | | | 155,938 | | | 279,282 | | | 155,936 | | | Effect of dilutive securities | | — | | | — | | | — | | | — | | | Weighted average ordinary shares outstanding - diluted | | 280,129 | | | 155,938 | | | 279,282 | | | 155,936 | | | Net loss per share attributable to common stockholders: | | | | | | | | | | Net loss per share from continuing operations - basic and diluted | | $ | (0.14) | | | $ | (0.21) | | | $ | (0.13) | | | $ | (0.25) | | | Net loss per share from discontinued operations, net of tax - basic and diluted | | (0.02) | | | — | | | (0.11) | | | (0.07) | | | Net loss per share - basic and diluted | | $ | (0.16) | | | $ | (0.21) | | | $ | (0.24) | | | $ | (0.32) | |
|
| Schedule of Antidilutive Securities Excluded from Computation of Net Income (Loss) per Share |
The outstanding securities that could potentially dilute basic net loss per share in the future that were not included in the computation of diluted net loss per share as the impact would be anti-dilutive are as follows (in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three months ended June 30, | | Six months ended June 30, | | | | 2026 | | 2025 | | 2026 | | 2025 | | | Redeemable preferred stock (on an as converted basis) | | 37,157 | | | 20,629 | | | 37,157 | | | 20,629 | | | 5.25% Convertible Notes due 2030 | | 23,232 | | | — | | | 23,232 | | | — | | | 4.00% Convertible Notes due 2031 | | 27,043 | | | — | | | 27,043 | | | — | | | | Convertible note - related party | | — | | | 12,521 | | | — | | | 12,521 | | | | Share purchase agreement | | — | | | 14,050 | | | — | | | 14,050 | | | | Public Warrants | | 16,331 | | | 14,675 | | | 16,331 | | | 14,675 | | | | Private Warrants | | 8,294 | | | 9,950 | | | 8,294 | | | 9,950 | | | | EDGE warrants | | — | | | 687 | | | — | | | 687 | | | | Options | | 4,792 | | | 8,459 | | | 4,792 | | | 8,459 | | | | RSUs | | 9,277 | | | 6,622 | | | 9,277 | | | 6,622 | | | Total | | 126,126 | | | 87,593 | | | 126,126 | | | 87,593 | | |
|